`
Wednesday, 28 June 2017

Australia News

  • Future of Healthcare in Asia

    Australia |  Analysis | By Amrita Tejasvi | 0 Comment | 05 May, 2014

    Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insurge of healthcare awareness, availability of technology and fast acce...Read more

  • Phylogica appoints CEO, CSO, CFO

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013

    Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new CEO as part of a broad company strategic review. He will be appointe...Read more

  • New South Wales govt launches Medical Devices Fund

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012

    Singapore: The New South Wales (NSW) Government in Australia has established a Medical Devices Fund under which it will aid development and commercialization of innovative medical devices i...Read more

  • Anteo Diagnostic to enter Korea market

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 20 Oct, 2015

    Singapore: Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distribution agreement with KomaBiotech, a Korean manufacturer and supplier...Read more

  • Australia's Anteo Diagnostics to acquire Belgium Dx firm

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015

    Singapore: Australia based Anteo Diagnostics has decided to acquire DIAsource ImmunoAssays, (DIAsource), a global specialty diagnostics company based in Belgium. DIAsource is a vertically-...Read more

  • Hatchtech gets patent for head lice cure, DeOvo

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2012

    Singapore: Australia-based specialty pharmaceutical company, Hatchtech, has been granted a patent by the US Patent and Trademark Office covering a key element of the company's novel head li...Read more

  • Challenge No 5: Talent trouble

    Australia |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key positions are problems in certain regions, especially for conducting R&...Read more

  • Funding uncertainty hinders Australian life science

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2012

    Singapore: A prominent healthcare industry leader sounded the alarm over Australia's system for approving government funding of new drugs. Dr Alan Robertson, CEO of Australian-based Pharmax...Read more

  • Sunshine Heart appoints Jon W Salveson to board

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013

    Singapore: Sunshine Heart, a medical devices company listed on Nasdaq and ASX, has appointed that Mr Jon W Salveson to the company's board of directors. Mr Salveson is the vice chairman, in...Read more

  • Dr Silviu Itescu: Pioneer of adult stem cell therapies

    Australia |  Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012

    A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New York and Melbourne with the sole objective of rapid development and ...Read more

  • Asian endoscopy market clocked $264.7 mn in 2012

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2013

    Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million in 2012 and estimates this to reach USD408.3 million in 2017, accordin...Read more

  • Japanese patent for Imugene drug delivery tech

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013

    Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug delivery technology Linguet. Japanese application provides protection aroun...Read more

  • Mesoblast appoints Dr Ben-Zion Weiner as non-executive director

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012

    Singapore: Dr Ben-Zion Weiner, special adviser to the CEO of Teva Pharmaceutical Industries, has been appointed as a non-executive director by Mesoblast. Dr Weiner has been leading Teva's g...Read more

  • mHealth apps market to reach $20.7 bn by 2018: Report

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2013

    Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in 2013 and will grow to $20.7 billion by 2018 at a CAGR of 25.50 percen...Read more

  • Elsevier, ARMS announce winners of Scopus award

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2012

    Singapore: Elsevier and the Australasian Research Management Society (ARMS) awarded the winners of the 3rd annual Scopus Young Researcher of the Year Awards 2012, at the ARMS 14th annual c...Read more

  • Merck partners with Aussie fertility technology firm

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 29 May, 2015

    Singapore: Merck, a leading company for innovative and top-quality high-tech products in healthcare, lifescience and performance materials, has collaborated with Australia based fertility t...Read more

  • Australian firm DoseMe raises $500k

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2014

    Singapore: In a bid to launch overseas and to expand its Australian operations, Brisbane-based personalised medicine start-up DoseMe has secured $500,000 in investment funding. The company...Read more

  • Sugar waste can be converted to pharma ingredient

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 04 Dec, 2012

    Singapore: Scientists at James Cook University (JCU) in Townsville, Queensland, Australia, used sunlight to convert a derivative of bagasse, known as furfural, into building blocks for high...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls